OBJECTIVE: Maternal obesity is a well-known risk factor for shortterm adverse perinatal outcomes. Studies show that obese patients have impaired immune function that leads to an increased susceptibility to infections. We sought to evaluate the long-term pediatric infectious morbidity of children born to obese patients. STUDY DESIGN: A population-based cohort analysis was performed comparing all deliveries of obese (maternal pre-pregnancy body mass index of 30 kg/m 2 or more) and non-obese patients between 1991-2014 at a single tertiary medical center. Hospitalizations of the offspring up to the age of 18 years involving infectious morbidities were evaluated according to a predefined set of ICD-9 codes, including: respiratory, gastrointestinal and urinary tract infections, pneumonia and bronchiolitis, meningitis, otitis and selected viral infections. Kaplan-Meier survival curve was used to compare cumulative hospitalization incidence between the groups. A Cox proportional hazards model was used to control for confounders. RESULTS: During the study period, 242,342 deliveries met the inclusion criteria. Of them, 3,290 were children of obese mothers. Hospitalizations involving infectious morbidity were significantly more common in children born to obese mothers compared with children born to non-obese patients (11.8% vs. 10.0%, OR¼1.21, 95% CI 1.10-1.35, p<0.01 , Table) . The Kaplan-Meier survival curve demonstrated a significantly higher cumulative incidence of infectious-related hospitalizations in the obese group (log rank p<0.01, Figure) . In the Cox regression model, while controlling for maternal age, gestational age, gestational diabetes, hypertensive disorders of pregnancy and mode of delivery, maternal obesity was found to be an independent risk factor for long-term infectious morbidity of the offspring (adjusted HR¼1.13, 95% CI 1.02-1.25, p¼0.01). CONCLUSION: Maternal obesity is an independent risk factor for longterm pediatric infectious morbidity of the offspring.
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856 Maternal obesity and long-term neuropsychiatric morbidity of the offspring enhanced vulnerability to brain injury. This study sought to evaluate the long-term pediatric neuropsychiatric morbidity, and specifically autistic spectrum disorders (ASD), of children born to obese patients as compared with children born to non-obese mothers. STUDY DESIGN: A population-based cohort analysis was performed comparing all deliveries of obese (maternal pre-pregnancy body mass index of 30 kg/m 2 or more) and non-obese patients between 1991-2014 at a single tertiary medical center. Hospitalizations of the offspring up to the age of 18 years involving neuropsychiatric morbidities were evaluated according to a predefined set of ICD-9 codes, including autistic, eating, sleeping and movement disorders, cerebral palsy, developmental disorders, and more. Kaplan-Meier survival curve was used to compare cumulative hospitalization rate in exposed and unexposed offspring. A Cox proportional hazards model was used to control for confounders. RESULTS: During the study period, 242,342 deliveries met the inclusion criteria. Of them, 3,290 were children of obese mothers. Hospitalizations involving neuropsychiatric morbidities were higher in children born to obese mothers compared with those born to non-obese mothers (4.0% vs. 3.1%, p<0.01, Table) . Specifically, offspring of obese mothers had higher rates of ASD and psychiatric disorders (Table) . The Kaplan-Meier survival curve demonstrated a significant higher cumulative incidence of neuropsychiatric-related hospitalizations in the obese group (Figure, log rank p¼0.03). Using a cox proportional hazards model, controlling for maternal age, preterm labor, maternal diabetes, hypertensive disorders of pregnancy and birthweight, maternal obesity was found to be independently associated with long-term neuropsychiatric morbidity of the offspring (adjusted HR¼1.23, 95% CI 1.04-1.47, p¼0.01). CONCLUSION: Maternal obesity is an independent risk factor for longterm neuropsychiatric morbidity of the offspring, and specifically ASD. However, due to our small numbers, the latter association should be further investigated.
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Seoul, Korea (Republic of), 3 Biomedical Research Institute, Seoul National University Hospital, Seoul, Seoul, Korea (Republic of) OBJECTIVE: Pregnant women with systemic lupus erythematosus (SLE) are at increased risk for adverse pregnancy outcomes (APOs) due to abnormal placentation. Identifying patients destined for APO early in pregnancy would significantly improve their obstetric outcomes. We sought to identify potential proteomic biomarkers in mid-trimester amniotic fluid of pregnant women with SLE for the prediction of APOs. STUDY DESIGN: The study population included 35 pregnant women with SLE who underwent clinically indicated amniocentesis at 15-24 weeks of gestation. Patients were divided into two groups: 19 women with normal pregnancy outcome (Group 1¼control group) and 16
